Advertisement

ADVERTISEMENT

Jessica Garlewicz, Associate Digital Editor

News
Basic Fibroblast Growth Factor Combined with Minoxidil Increases Efficacy and Patient Satisfaction in AGA
01/26/2022
Jessica Garlewicz, Associate Digital Editor
A study found that there was an improvement in treatment efficiency and patient satisfaction when using basic fibroblast growth factor combined with 5% minoxidil for treating male patients with early stage of androgenetic alopecia.
A study found that there was an improvement in treatment efficiency and patient satisfaction when using basic fibroblast growth factor combined with 5% minoxidil for treating male patients with early stage of androgenetic alopecia.
A study found that there was an...
01/26/2022
The Dermatologist
FDA Alerts
FDA Approves Risankizumab-rzaa for Adult Patients With Active Psoriatic Arthritis
01/24/2022
Jessica Garlewicz, Associate Digital Editor
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already...
01/24/2022
The Dermatologist
News
PEST and EARP Efficient for the Diagnosis of Juvenile Psoriatic Arthritis in Pediatric Patients With Psoriasis
01/24/2022
Jessica Garlewicz, Associate Digital Editor
Researchers found the Psoriasis Epidemiology Screening Tool (PEST) and the new Early Arthritis for Psoriatic Patients (EARP) questionnaires were efficient in diagnosing juvenile psoriatic arthritis.
Researchers found the Psoriasis Epidemiology Screening Tool (PEST) and the new Early Arthritis for Psoriatic Patients (EARP) questionnaires were efficient in diagnosing juvenile psoriatic arthritis.
Researchers found the Psoriasis...
01/24/2022
The Dermatologist
News
JAK1 Inhibitor Safe, Effective for Patients With Moderate-to-Severe HS
01/18/2022
Jessica Garlewicz, Associate Digital Editor
In their recent trials, researchers examined the tolerability of Janus kinase 1 inhibitor INCB054707, and evaluated efficacy measures including HS Clinical Response.
In their recent trials, researchers examined the tolerability of Janus kinase 1 inhibitor INCB054707, and evaluated efficacy measures including HS Clinical Response.
In their recent trials,...
01/18/2022
The Dermatologist
News
Women With Psoriasis: Maternal and Neonatal Outcomes
01/14/2022
Jessica Garlewicz, Associate Digital Editor
Researchers aimed to evaluate associations between psoriasis and pregnancy, including maternal and newborn outcomes.
Researchers aimed to evaluate associations between psoriasis and pregnancy, including maternal and newborn outcomes.
Researchers aimed to evaluate...
01/14/2022
The Dermatologist
News
Daily Low Emission Phototherapy Effects in Psoriasis
01/05/2022
Jessica Garlewicz, Associate Digital Editor
The authors noted that while low-dose UV treatment has been effective in mild psoriasis, safety concerns over prolonged use of this treatment modality may have risen.
The authors noted that while low-dose UV treatment has been effective in mild psoriasis, safety concerns over prolonged use of this treatment modality may have risen.
The authors noted that while...
01/05/2022
The Dermatologist
News
Biologic Treatment Elevates Dual Specificity Phosphatase 22 in Psoriasis
01/05/2022
Jessica Garlewicz, Associate Digital Editor
The study authors aimed to find the correlation between dual specificity phosphatase 22 and clinical features and treatment outcomes in patients with psoriasis.
The study authors aimed to find the correlation between dual specificity phosphatase 22 and clinical features and treatment outcomes in patients with psoriasis.
The study authors aimed to find...
01/05/2022
The Dermatologist
News
The Effects of Age on Hidradenitis Suppurativa Self-Rated Pain
12/08/2021
Jessica Garlewicz, Associate Digital Editor
Prior to this study, the authors had observed that there was a dissociation between pain and number of HS lesions with increasing age.
Prior to this study, the authors had observed that there was a dissociation between pain and number of HS lesions with increasing age.
Prior to this study, the authors...
12/08/2021
The Dermatologist
NEA Approved Features
How an Atopic Dermatitis Biologic May Affect COVID-19 Infection
12/08/2021
Jessica Garlewicz, Associate Digital Editor
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found...
12/08/2021
The Dermatologist
News
Toronto Psoriatic Arthritis Screen 2 Utilized as a Screening Tool for Psoriasis
12/03/2021
Jessica Garlewicz, Associate Digital Editor
In a recent study, researchers aimed to evaluate the skin-specific questions from the Toronto Psoriatic Arthritis Screen, version 2 (ToPAS 2) utilized for the diagnosis of psoriasis.
In a recent study, researchers aimed to evaluate the skin-specific questions from the Toronto Psoriatic Arthritis Screen, version 2 (ToPAS 2) utilized for the diagnosis of psoriasis.
In a recent study, researchers...
12/03/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use